CD274 and neoplasm: Moreover, tumor heterogeneity can be a reason that PD-L1 expression status may differ between primary tumor and metastatic lesions, hypothesizing that the predictive accuracy of PD-L1 is depending on the time of biopsy, being related to previous therapies [18, 33].